慢性疼痛的分子机制与治疗干预

Molecular Mechanisms of Chronic Pain and Therapeutic Interventions.

作者信息

Li Zhen, Li Xing, Liu Jieqiong, Sun Rao, Ye Yingze, Xiang Hongbing, Luo Fang, Li Shiyong, Luo Ailin

机构信息

Department of Anesthesiology and Pain Medicine Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health and Wuhan Clinical Research Center for Geriatric Anesthesia Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China.

出版信息

MedComm (2020). 2025 Aug 7;6(8):e70325. doi: 10.1002/mco2.70325. eCollection 2025 Aug.

Abstract

Chronic pain imposes incalculable health and economic burdens, affecting more than 30% of the global population in published studies. Optimal management of chronic pain is imperative for individuals experiencing such distress. Nevertheless, the current approaches to chronic pain assessment and treatment fail to meet clinical requirements. In recent years, there has been a growing recognition of the need for precision medicine approaches to effectively manage chronic pain. Chronic pain can be classified into three categories: nociceptive (resulting from tissue injury), neuropathic (caused by nerve injury), or nociplastic (arising from a sensitized nervous system). These classifications significantly impact the evaluation and treatment decisions at all levels. Significantly, in practice, there is substantial overlap in chronic pain mechanisms among patients and within different types of chronic pain. The application of precision medicine is imperative in the management of chronic pain. This review offers a comprehensive overview of the distinctive molecular mechanisms underlying nociceptive, neuropathic, and nociplastic pain, including immune responses, ion channels, monoaminergic imbalance, and neuroinflammation. Subsequently, we summarized the status quo of nociceptive, neuropathic, and nociplastic pain manipulation. Last, we explored the advances in pain management strategies for chronic pain that are making significant progress toward their clinical implementation.

摘要

慢性疼痛带来了难以估量的健康和经济负担,在已发表的研究中,全球超过30%的人口受到影响。对于遭受此类痛苦的个人而言,慢性疼痛的优化管理至关重要。然而,目前慢性疼痛的评估和治疗方法未能满足临床需求。近年来,人们越来越认识到需要采用精准医学方法来有效管理慢性疼痛。慢性疼痛可分为三类:伤害感受性疼痛(由组织损伤引起)、神经病理性疼痛(由神经损伤导致)或神经可塑性疼痛(源于敏感的神经系统)。这些分类在各个层面上对评估和治疗决策都有重大影响。重要的是,在实践中,患者之间以及不同类型的慢性疼痛内部,慢性疼痛机制存在大量重叠。精准医学在慢性疼痛管理中势在必行。本综述全面概述了伤害感受性、神经病理性和神经可塑性疼痛背后独特的分子机制,包括免疫反应、离子通道、单胺能失衡和神经炎症。随后,我们总结了伤害感受性、神经病理性和神经可塑性疼痛处理的现状。最后,我们探讨了慢性疼痛管理策略的进展,这些进展正朝着临床应用取得重大进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db78/12331885/5f6ad52c929b/MCO2-6-e70325-g004.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索